MOG-IgA as a potential marker of germinal center activity by Handel, AE, Irani, SR, Leite, MI

NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia by Savage, SA, Irani, SR, Leite, MI, Zeman, AZ

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes by Michael, S, Leite, MI, Sen, A, Waters, P, Irani, SR

AB009. Spatial proteomic analysis of the human thymic microenvironment shaping T cell development by Hanna, KS, Deadman, ME, Handel, A, Leite, MI, Holländer, GA

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients by Whittam, DH, Cobo-Calvo, A, Lopez-Chiriboga, AS, Leite, MI, Palace, J

Myasthenia gravis in 2025: five new things and four hopes for the future by Binks, SNM, Morse, IM, Ashraghi, M, Vincent, A, Waters, P, Leite, MI

Frequency of MOG-IgG in cerebrospinal fluid versus serum by Pace, S, Orrell, M, Woodhall, M, Palace, J, Leite, MI, Irani, S, Waters, P, Handel, AE

‘Less contented as a person’: an update from the LGI1-QoL study by Binks, S, Veldsman, M, Jacob, S, Maddison, P, Coebergh, J, Leite, MI, Husain, M, Irani, SR

A challenging case of hypercapnic respiratory failure during pregnancy. by Vijayakumar, B, Cao, M, Mackillop, L, Sarangmat, N, Leite, MI, Wathen, CG, Nickol, AH, Turnbull, CD

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing by Binks, S, Veldsman, M, Jacob, S, Maddison, P, Coebergh, J, Michael, S, Ramanathan, S, Leite, MI, Husain, M, Irani, SR

International multicenter examination of MOG antibody assays by Reindl, M, Schanda, K, Woodhall, M, Ramberger, M, Leite, MI, Palace, J, Irani, SR, Waters, P

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies by Yeo, T, Dos Passos, GR, Muhammed, L, Everett, R, Reeve, S, Messina, S, Probert, F, Leite, MI, Jacqueline Palace

No strong HLA association with MOG antibody disease in the UK population by Grant-Peters, M, Passos, GRD, Yeung, H-Y, Jacob, A, Huda, S, Dendrou, CA, Leite, MI, Palace, J

A tumultuous case of episodic apnoea by Sun, B, Mgbachi, V, Woodhall, M, Voysey, Z, Azzopardi, L, Rajan, P, Wroe, S, Waters, P, Leite, MI, Irani, S

Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder by Francis, A, Gibbons, E, Yu, J, Johnston, K, Rochon, H, Powell, L, Leite, MI, Huda, S, Kielhorn, A, Palace, J

Teratoma-derived glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus by Sun, B, Mgbachi, V, Woodhall, M, Makuch, M, Azzopardi, L, Rajan, P, Wroe, S, Waters, P, Leite, MI, Irani, SR

Improvement of fatigue in generalised myasthenia gravis with zilucoplan by Weiss, MD, Freimer, M, Leite, MI, Maniaol, A, Utsugisawa, K, Bloemers, J, Boroojerdi, B, Howard, E, Savic, N, Howard, JF

Glycine receptor autoantibodies disrupt inhibitory neurotransmission by Crisp, SJ, Dixon, CL, Jacobson, L, Chabrol, E, Irani, SR, Leite, MI, Leschziner, G, Slaght, SJ, Vincent, A, Kullmann, DM

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling by Yeo, T, Probert, F, Jurynczyk, M, Sealey, M, Cavey, A, Claridge, TDW, Woodhall, M, Waters, P, Leite, MI, Anthony, DC, Palace, J

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease. by Dos Passos, GR, Elsone, L, Luppe, S, Kitley, J, Messina, S, Rodríguez Cruz, PM, Harding, K, Mutch, K, Leite, MI, Robertson, N, Jacob, A, Palace, J